The Current Ratio as of December 2024 (TTM) for Taisho Pharmaceutical Holdings Co., Ltd. (TAIPY) is 5.16

According to Taisho Pharmaceutical Holdings Co., Ltd.’s latest financial reports and current stock price. The company's current Current Ratio is 5.16. This represents a change of 0.75% compared to the average of 5.12 of the last 4 quarters.

Taisho Pharmaceutical Holdings Co., Ltd. (TAIPY) Historical Current Ratio (quarterly & annually)

How has TAIPY Current Ratio performed in the past?

The mean historical Current Ratio of Taisho Pharmaceutical Holdings Co., Ltd. over the last ten years is 5.51. The current 5.16 Current Ratio has changed 9.26% with respect to the historical average. Over the past ten years (40 quarters), TAIPY's Current Ratio was at its highest in in the June 2019 quarter at 8.61. The Current Ratio was at its lowest in in the March 2014 quarter at 3.70.

Taisho Pharmaceutical Holdings Co., Ltd. (TAIPY) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Taisho Pharmaceutical Holdings Co., Ltd. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Taisho Pharmaceutical Holdings Co., Ltd. (TAIPY) Average Current Ratio

How has TAIPY Current Ratio performed in the past?

The current Current Ratio of Taisho Pharmaceutical Holdings Co., Ltd. (TAIPY) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Taisho Pharmaceutical Holdings Co., Ltd. (TAIPY) Current Ratio vs. Peers

How is TAIPY’s Current Ratio compared to its peers?

Taisho Pharmaceutical Holdings Co., Ltd.’s Current Ratio is less than Shionogi & Co., Ltd. (7.07), less than Vivesto AB (5.95), greater than Acorda Therapeutics, Inc. (0.22), greater than Pacira BioSciences, Inc. (2.25), less than Haleon plc (0), greater than Dr. Reddy's Laboratories Limited (0.84), greater than Emergent BioSolutions Inc. (1.92), greater than HUTCHMED (China) Limited (2.88), greater than Viatris Inc. (2.81), greater than Teva Pharmaceutical Industries Limited (1.51), greater than Elanco Animal Health Incorporated (0.89), greater than Catalent, Inc. (2.55), greater than Mallinckrodt plc (2.51), greater than null (2.74),

Build a custom stock screener for Taisho Pharmaceutical Holdings Co., Ltd. (TAIPY) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Taisho Pharmaceutical Holdings Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Taisho Pharmaceutical Holdings Co., Ltd. (TAIPY) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Taisho Pharmaceutical Holdings Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.